Adam Kolom is a biotech entrepreneur and private equity investor. Adam has co-founded 6 companies, led two of the world’s largest cancer immunotherapy research initiatives, and has overseen more than $850 million in biotechnology and healthcare investments. Adam currently serves as co-founder and CEO of Related Sciences, a data science-driven drug discovery studio that aims to systematically improve biotech’s rates of success in discovering important new medicines for patients. Prior to founding Related Sciences, Adam co-founded Sean Parker’s $250 million nonprofit, the Parker Institute for Cancer Immunotherapy, where he worked closely with Sean designing the Institute, assembling its network of centers, building its roster of scientific talent, and leading over 40 biopharma partnerships. Before PICI, Adam was Managing Director of the Cancer Research Institute’s venture capital fund and global clinical trials program, a member of the healthcare private equity team at General Atlantic, and a management consultant at McKinsey & Company. Adam graduated with honors from the Wharton School at UPenn with a degree in finance and economics. He lives in Los Angeles.